CN112870256A - Traditional Chinese medicine composition for treating rhinitis - Google Patents
Traditional Chinese medicine composition for treating rhinitis Download PDFInfo
- Publication number
- CN112870256A CN112870256A CN202110263315.5A CN202110263315A CN112870256A CN 112870256 A CN112870256 A CN 112870256A CN 202110263315 A CN202110263315 A CN 202110263315A CN 112870256 A CN112870256 A CN 112870256A
- Authority
- CN
- China
- Prior art keywords
- parts
- traditional chinese
- chinese medicine
- medicine composition
- treating rhinitis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
- A61K36/575—Magnolia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Otolaryngology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a medicine for treating rhinitis, in particular to a traditional Chinese medicine composition for treating rhinitis. The traditional Chinese medicine composition for treating rhinitis comprises the following components in parts by weight: 10-15 parts of magnolia flower; 10-15 parts of radix angelicae; 10-15 parts of mint; 5-10 parts of borneol. The preparation method comprises grinding flos Magnoliae, radix Angelicae Dahuricae, herba Menthae and Borneolum into powder, and mixing to obtain the final product. The traditional Chinese medicine composition for treating rhinitis provided by the invention enables the efficacy of a medicine to directly reach the focus of infection, has concentrated efficacy and reliable curative effect, can obviously improve the clinical symptoms and signs of allergic rhinitis patients, and has no obvious toxic or side effect and adverse reaction.
Description
Technical Field
The invention relates to a medicine for treating rhinitis, in particular to a traditional Chinese medicine composition for treating rhinitis.
Background
Rhinitis is acute or chronic or acute inflammation of the nasal mucosa or submucosal tissue caused by viral infection, bacterial infection, irritation of irritants, etc., which results in damage to the nasal mucosa or submucosal tissue. Rhinitis causes excessive mucus, often resulting in runny nose, nasal obstruction, etc. The symptoms of rhinitis are different from hay fever, the symptoms of perennial rhinitis are mild, heavy and generally unpredictable all year round, symptoms (such as conjunctivitis) outside the nose are rare, but chronic and acute nasal obstruction is generally obvious and can develop into eustachian tube obstruction, and the hearing is reduced as a result, and even some patients can have symptoms such as paranasal sinus infection and nasal polyp.
The traditional method for treating rhinitis mainly comprises physical therapy, surgical therapy, drug therapy and the like, but the treatment process is long, is extremely easy to repeat, and is difficult to radically treat.
Disclosure of Invention
Aiming at the defects in the prior art, the traditional Chinese medicine composition for treating rhinitis provided by the invention solves the technical problems and provides a traditional Chinese medicine composition capable of effectively treating rhinitis.
In order to achieve the purpose, the invention provides the following technical scheme:
a traditional Chinese medicine composition for treating rhinitis comprises the following components in parts by weight: 10-15 parts of magnolia flower; 10-15 parts of radix angelicae; 10-15 parts of mint; 5-10 parts of borneol.
A traditional Chinese medicine composition for treating rhinitis comprises the following components in parts by weight: 10 parts of magnolia flower; 10 parts of radix angelicae; 10 parts of mint; 10 parts of borneol.
A traditional Chinese medicine composition for treating rhinitis comprises the following components in parts by weight: 10 parts of magnolia flower; 15 parts of radix angelicae; 15 parts of mint; 10 parts of borneol.
A Chinese medicinal composition for treating rhinitis comprises the following components in parts by weight; 12 parts of magnolia flower; 11 parts of radix angelicae; 13 parts of mint; 8 parts of borneol.
A traditional Chinese medicine composition for treating rhinitis comprises the following components in parts by weight: 13 parts of magnolia flower; 14 parts of radix angelicae; 11 parts of mint; 7 parts of borneol.
The traditional Chinese medicine composition for treating rhinitis is prepared by the following method: grinding flos Magnoliae, radix Angelicae Dahuricae, herba Menthae and Borneolum into powder of 60-80 meshes; and mixing the powders to obtain the final product.
The invention has the beneficial effects that: the traditional Chinese medicine composition for treating rhinitis provided by the invention adopts natural traditional Chinese medicine raw materials for all components, and has the advantages of simple preparation, wide medicine sources and low cost. The traditional Chinese medicine has synergistic effect in drug effect, has effects of clearing heat, promoting diuresis, removing turbid, dredging orifice, moistening lung, eliminating phlegm, invigorating spleen, invigorating qi, dredging orifice, relieving pain, dispelling pathogenic wind and heat, clearing head and eyes, relieving exterior syndrome, dispelling cold, etc., and has remarkable effects in treating rhinitis caused by spleen and stomach damp-heat, exogenous pathogenic factors invasion, pathogenic factors invasion and heat transformation, putridity, pus generation, retention of empty orifice, dispersion and emptying, clear turbidity, and orifice blockage. Can rapidly and thoroughly relieve inflammation of nasal mucosa and submucosa.
Allergic rhinitis belongs to the category of allergic rhinitis in traditional Chinese medicine, mostly shows insufficiency of yang qi, and is often induced by climate change, cold drinking or rest insufficiency, and overstrain. The etiology of the disease is considered to be that the body is deficient in yang qi, and the defense function is low, so that exogenous pathogenic factors are easy to invade. Clinical practice shows that the traditional Chinese medicine composition has unique curative effect on allergic rhinitis and achieves the purpose of treating the allergic rhinitis.
For a better understanding of the features and technical content of the present invention, refer to the following detailed description of the invention.
Detailed Description
To further illustrate the technical means adopted by the present invention and the effects thereof, the following detailed description is given with reference to the preferred embodiments of the present invention.
A traditional Chinese medicine composition for treating rhinitis comprises the following components in parts by weight: 10-15 parts of magnolia flower; 10-15 parts of radix angelicae; 10-15 parts of mint; 5-10 parts of borneol.
Example 1:
a traditional Chinese medicine composition for treating rhinitis comprises the following components in parts by weight: 10 parts of magnolia flower; 10 parts of radix angelicae; 10 parts of mint; 10 parts of borneol.
A traditional Chinese medicine composition for treating rhinitis is prepared by the following method: grinding flos Magnoliae, radix Angelicae Dahuricae, herba Menthae and Borneolum into 60 mesh powder; and mixing the powders to obtain the final product.
Example 2:
a traditional Chinese medicine composition for treating rhinitis comprises the following components in parts by weight: 10 parts of magnolia flower; 15 parts of radix angelicae; 15 parts of mint; 10 parts of borneol.
A traditional Chinese medicine composition for treating rhinitis is prepared by the following method: grinding flos Magnoliae, radix Angelicae Dahuricae, herba Menthae and Borneolum Syntheticum into 70 mesh powder; and mixing the powders to obtain the final product.
Example 3:
a traditional Chinese medicine composition for treating rhinitis comprises the following components in parts by weight: 12 parts of magnolia flower; 11 parts of radix angelicae; 13 parts of mint; 8 parts of borneol.
A traditional Chinese medicine composition for treating rhinitis is prepared by the following method: grinding flos Magnoliae, radix Angelicae Dahuricae, herba Menthae and Borneolum into 80 mesh powder; and mixing the powders to obtain the final product.
Example 4:
a traditional Chinese medicine composition for treating rhinitis comprises the following components in parts by weight: 13 parts of magnolia flower; 14 parts of radix angelicae; 11 parts of mint; 7 parts of borneol.
A traditional Chinese medicine composition for treating rhinitis is prepared by the following method: grinding flos Magnoliae, radix Angelicae Dahuricae, herba Menthae and Borneolum into 80 mesh powder; and mixing the powders to obtain the final product.
The using method comprises the following steps:
putting a proper amount of finished product prepared from the traditional Chinese medicine composition for treating rhinitis into the nostril, and inhaling into the nose. In addition, the product prepared from the Chinese medicinal composition for treating rhinitis can be blown out after being ignited, and the smoke can be inhaled into nasal cavity. The method is used for treating rhinitis.
Typical cases are as follows:
in summer, male, Guangxi, 2015 had nasal obstruction and stuffy nose and nasal discharge, which were often accompanied by cold. The traditional Chinese medicine composition for treating rhinitis in the embodiment 2 of the invention is used three times a day, rhinitis symptoms are completely eliminated after 30 days, no allergic symptoms occur in the medicine taking process, inflammation is healed after two months, and no sequela exists after healing.
Wangzhi, male, 60 years old. The medical history: the nasal obstruction is heavy at night, accompanied by a small amount of white and thick nasal discharge, poor in resistance, susceptible to cold, blown by cold wind recently, aggravated in nasal obstruction, reduced in appetite, reduced in sleep quality, examined in hospitals, congestion and swelling of mucous membranes of inferior turbinates, changed in a polypoid form, pale in tongue, white in fur and wiry in pulse, the traditional Chinese medicine composition for treating rhinitis, which is obtained in the embodiment 1, is taken for 2 times a day, is ignited by fire and then blown out, and smoke is sucked into the nasal cavity for 20 days as a treatment course. After the oral liquid is taken for one week, the nasal obstruction is relieved, the appetite is increased, after a course of administration, the nasal obstruction is basically relieved, the nasal obstruction is occasionally caused, the nasal obstruction is continuously taken for a course of treatment, the nasal obstruction of a patient is completely disappeared, the appetite is normal, the immunity is enhanced, the number of cold is reduced compared with that before treatment, and the cold does not relapse within one year of follow-up visit.
100 patients with allergic rhinitis are clinically observed in 3 years, and the clinical report of the traditional Chinese medicine composition is as follows:
1. general data of 100 patients, the age is 15-69 years, the disease course is more between 1 month and 3 years, and the average age is 29 years.
2. The diagnosis standard is based on the therapeutic standard for diagnosis of traditional Chinese medicine diseases issued by the State administration of traditional Chinese medicine:
the main symptoms of paroxysmal rhinocnesmus, continuous sneezing, nasal obstruction and clear and thin nasal discharge are accompanied by symptoms of sniffing, itching eyes, throat itching and the like; the disease starts rapidly, the symptoms generally last for a plurality of minutes to tens of minutes, and the intermittent period has no sneezing and nasal obstruction and can be complicated with diseases such as urticaria, asthma and the like; frequently, the disease is caused by exposure to allergens such as pollen, smoke, chemical gases, etc., and may be induced by environmental temperature changes.
3. The application method is respectively adopted 3 times a day, and each method is 50 people.
4. The treatment results are as follows: 4.1, the method is formulated according to the guiding principle of clinical research of new traditional Chinese medicines:
and (3) healing: after the medicine is taken, the symptoms disappear, and no relapse occurs for more than 3 months;
the effect is shown: symptoms and physical signs are relieved during attack, the frequency is reduced, but the symptoms and physical signs do not disappear completely;
and (4) invalidation: with little or no change in symptoms and signs.
The total cure rate of 50 patients who use the two application methods in 100 patients is 45, the effect is obvious, the effect is 5 patients, and the total effective rate is 95%.
The above description is only for the specific embodiments of the present invention, but the scope of the present invention is not limited thereto, and any person skilled in the art can easily conceive of the changes or substitutions within the technical scope of the present invention, and all the changes or substitutions should be covered within the scope of the present invention. Therefore, the protection scope of the present invention shall be subject to the protection scope of the claims.
Claims (6)
1. The traditional Chinese medicine composition for treating rhinitis is characterized by comprising the following components in parts by weight: 10-15 parts of magnolia flower; 10-15 parts of radix angelicae; 10-15 parts of mint; 5-10 parts of borneol.
2. The traditional Chinese medicine composition for treating rhinitis according to claim 1, which is characterized by comprising the following components in parts by weight: 10 parts of magnolia flower; 10 parts of radix angelicae; 10 parts of mint; 10 parts of borneol.
3. The traditional Chinese medicine composition for treating rhinitis according to claim 1, which is characterized by comprising the following components in parts by weight: 10 parts of magnolia flower; 15 parts of radix angelicae; 15 parts of mint; 10 parts of borneol.
4. The traditional Chinese medicine composition for treating rhinitis according to claim 1, which is characterized by comprising the following components in parts by weight: 12 parts of magnolia flower; 11 parts of radix angelicae; 13 parts of mint; 8 parts of borneol.
5. The traditional Chinese medicine composition for treating rhinitis according to claim 1, which is characterized by comprising the following components in parts by weight: 13 parts of magnolia flower; 14 parts of radix angelicae; 11 parts of mint; 7 parts of borneol.
6. The traditional Chinese medicine composition for treating rhinitis according to claim 1, which is prepared by the following method: grinding flos Magnoliae, radix Angelicae Dahuricae, herba Menthae and Borneolum into powder of 60-80 meshes; and mixing the powders to obtain the final product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110263315.5A CN112870256A (en) | 2021-03-11 | 2021-03-11 | Traditional Chinese medicine composition for treating rhinitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110263315.5A CN112870256A (en) | 2021-03-11 | 2021-03-11 | Traditional Chinese medicine composition for treating rhinitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112870256A true CN112870256A (en) | 2021-06-01 |
Family
ID=76054273
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110263315.5A Pending CN112870256A (en) | 2021-03-11 | 2021-03-11 | Traditional Chinese medicine composition for treating rhinitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112870256A (en) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101623328A (en) * | 2008-07-08 | 2010-01-13 | 孙敬兰 | Chinese medicinal preparation and its preparation method |
| CN101703574A (en) * | 2009-12-03 | 2010-05-12 | 秦开锋 | Medicament for treating sinusitis |
| CN102793747A (en) * | 2011-05-25 | 2012-11-28 | 张艳忠 | Chinese medicinal magnolia flower and angelica dahurica powder for treating chronic rhinitis |
| CN104127496A (en) * | 2014-07-22 | 2014-11-05 | 韩峥华 | Rhinitis and nasosinusitis treatment medicine |
| CN104800742A (en) * | 2015-05-15 | 2015-07-29 | 王健军 | Chinese medicinal composition for treating rhinitis and preparation method thereof |
| CN107837369A (en) * | 2017-12-11 | 2018-03-27 | 莫爱建 | Treat the Chinese medicine composition of rhinitis |
-
2021
- 2021-03-11 CN CN202110263315.5A patent/CN112870256A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101623328A (en) * | 2008-07-08 | 2010-01-13 | 孙敬兰 | Chinese medicinal preparation and its preparation method |
| CN101703574A (en) * | 2009-12-03 | 2010-05-12 | 秦开锋 | Medicament for treating sinusitis |
| CN102793747A (en) * | 2011-05-25 | 2012-11-28 | 张艳忠 | Chinese medicinal magnolia flower and angelica dahurica powder for treating chronic rhinitis |
| CN104127496A (en) * | 2014-07-22 | 2014-11-05 | 韩峥华 | Rhinitis and nasosinusitis treatment medicine |
| CN104800742A (en) * | 2015-05-15 | 2015-07-29 | 王健军 | Chinese medicinal composition for treating rhinitis and preparation method thereof |
| CN107837369A (en) * | 2017-12-11 | 2018-03-27 | 莫爱建 | Treat the Chinese medicine composition of rhinitis |
Non-Patent Citations (1)
| Title |
|---|
| 张永泉等: "中西医结合治疗慢性鼻炎的临床观察", 《中国医药导报》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103301254B (en) | Antibacterial liquid used for nasopharyal meatus and preparation method thereof | |
| CN111067935A (en) | Rhinitis medicine and preparation method thereof | |
| CN105012487B (en) | Children's nose, which relaxes, leads to nasal drops | |
| CN103623267A (en) | Medication for treating allergic rhinitis | |
| CN110638915A (en) | Traditional Chinese medicine composition for treating chronic rhinitis and preparation method thereof | |
| CN112870256A (en) | Traditional Chinese medicine composition for treating rhinitis | |
| CN101904979A (en) | Medicine for treating chronic pharyngitis | |
| CN114767824A (en) | Preparation for treating laryngeal cough and preparation method thereof | |
| CN109106774B (en) | Traditional Chinese medicine composition for treating adenoidal hypertrophy and complications thereof, and preparation method and application thereof | |
| CN102133280B (en) | Chinese herbal medicine pill for treating pharyngitis and esophagitis | |
| CN1660256A (en) | Medication for treating cough caused by inflammation of upper respiratory tract | |
| CN105748899A (en) | Pharmaceutical preparation for treating pharyngitis and use thereof | |
| CN104547128A (en) | Medicine for treating rhinitis | |
| CN104857075A (en) | Traditional Chinese medicinal composition for treating rhinitis, nasal polyp and sphagitis, and preparation method thereof | |
| CN110013507A (en) | A kind of Chinese medicine composition for treating mixed type rhinitis | |
| CN114099579B (en) | Traditional Chinese medicine composition for treating adenoidal hypertrophy and complications thereof, and preparation method and application thereof | |
| CN101978968B (en) | Medicament for treating tympanitis | |
| CN1277551C (en) | Mint oil preparation for treating obstructive sleep apnea and low ventilation syndrome | |
| CN104784384A (en) | Traditional Chinese medicine for treating pharyngitis | |
| CN103463236B (en) | Medicinal composition and preparation method thereof | |
| CN105056060A (en) | Medicine for treating chronic nasosinusitis | |
| CN112022936A (en) | Tonsil health-care patch and preparation method thereof | |
| CN104524297A (en) | Traditional Chinese medicine for treating kidney-yang insufficiency type allergic rhinitis | |
| CN111714552A (en) | Traditional Chinese medicine formula for inactivating virus and blocking infection vaporization therapy | |
| CN116211932A (en) | Medicine for treating rhinitis combined with acute pharyngitis caused by wind-heat of lung channel and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210601 |